Alerts
Other content recommended for you
- Vaccination leads to an aberrant FOXP3 T-cell response in non-remitting juvenile idiopathic arthritis
- Cross-border healthcare in the European Union: clarifying patients’ rights
- Children with extended oligoarticular and polyarticular juvenile idiopathic arthritis have alterations in B and T follicular cell subsets in peripheral blood and a cytokine profile sustaining B cell activation
- Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases
- Cross-border care and healthcare quality improvement in Europe: the MARQuIS research project
- Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups
- Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study
- Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period
- Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study
- Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis